Medicare Advantage — the private insurance alternative to traditional Medicare — covers approximately 54% of all Medicare beneficiaries in 2025 and is the most commercially significant growth driver in the health insurance industry. The program's star rating system creates powerful financial incentives for quality improvement, while risk adjustment methodology determines the accuracy of premium payments to plans. UnitedHealthcare, Humana, CVS Aetna, and Elevance Health are the four largest Medicare Advantage plans by enrollment. The 2025 Medicare Advantage market was characterized by elevated medical cost trends, CMS funding reductions, and membership losses at Humana and others that reset margin expectations across the industry.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Medicare Advantage Market Dynamics
• Enrollment by Plan 2025
• CMS Star Ratings
• Risk Adjustment
• Funding Dynamics and CMS Rate Notices
• Leading Plan Strategies
• Medicare Advantage Outlook 2026-2030
Table of Contents
1. Executive Summary
2. Market Overview
3. Medicare Advantage Market Dynamics
4. Enrollment by Plan 2025
5. CMS Star Ratings
6. Risk Adjustment
7. Funding Dynamics and CMS Rate Notices
8. Leading Plan Strategies
9. Medicare Advantage Outlook 2026-2030
10. Competitive Landscape
11. Regional Market Analysis
12. Strategic Conclusions and Recommendations
13. Appendix
List of Tables
Table 1. Market Overview and Key Data 2025
Table 2. Competitive Landscape 2025
Table 3-8. Topic-Specific Analysis Tables
Table 3. Leading Companies — Portfolio and Strategy Assessment 2025
Table 4. M&A and Partnership Activity 2023-2025
Table 5. Regional Analysis
Table 6. Key Risks and Mitigation Strategies
Companies Profiled
Aetna
Centene
Cigna
CVS Health
Elevance Health
Humana
Molina Healthcare
UnitedHealth Group
